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Abstract
The success of pre-operative therapy over post-operative treatments means that a technique identifying prognostic
factors pre-operatively is of potential benefit in modifying the intensity of pre-operative therapy according to risk
of local or distant failure. Clinical trials incorporating robust and accurate assessment of prognostic factors and
appropriate stratification of patients prior to therapy will enable objective comparison of treatment modalities and
outcomes. Careful staging of rectal tumours results in selective pre-operative treatment strategies aimed at reducing
local failure and distant failure in high risk patients.
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Imaging and pre-operative strategies
Surgical and pre-operative treatment choices are best
determined by multidisciplinary decision making based
on detailed assessment of the primary tumour, as well
as staging for the presence or absence of metastatic dis-
ease. The following prognostic factors are taken into con-
sideration in the diagnosis and staging of rectal cancer by




By assessing tumour penetration (hypoechoic mass
lesion) in relation to rectal wall layers, it is possible to
provide an ultrasound T stage which correlates well with
the T component of the TNM classification (Fig. 1)[1].
Overstaging of T2 lesions is well described and is caused
by peritumoral inflammation merging imperceptibly
with primary tumour and can also occur with oblique
scanning and over-distension of the coupling balloon.
Conversely understaging occurs less commonly, and
is the result of microscopic tumour infiltration below
the resolution capabilities of ultrasound. A subgroup of
patients exists (sm1 disease) who can be treated with
curative intent by a variety of minimally invasive
techniques at colonoscopy by performing endoscopic
polypectomy and endoscopic mucosal resection (EMR).
Although the 15-MHz miniprobe[2] showed disappoint-
ing accuracy (37.1%) in distinguishing between the
three subclasses of submucosal invasion (sm1, 2 and 3)
a higher accuracy was achieved in discriminating
between sm1 (m and sm1) and sm2 (85.7%).
MRI
MRI assessment using high spatial resolution techniques
shows similar accuracy and limitations in T-staging as
ultrasound. Both T1 and T2 tumours have a very high
5-year survival but the widest range in survival is demon-
strated in patients with T3 tumours which comprise 80%
of patients. For example, a T3 tumour with only 12mm
of extramural spread has an identical prognosis to
T2 tumours. The successful identification of tumours
with increasing extramural spread is of great importance
as histopathology studies have shown poor survival in
this group of patients. Using MRI, the majority of
patients with tumour infiltrating 5mm or over beyond
the muscularis propria are correctly identified and
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extramural depth, as measured using MRI, shows direct
agreement with corresponding histopathological mea-
surements. The anterior wall of the upper rectum is
covered by the peritoneal reflection and transcoelomic
spread with disseminated intra-abdominal disease will
occur if there is ulceration through the peritoneum.
Obvious tumour spread through and beyond the perito-
neal reflection can be readily identified by MRI, but not
by ultrasound. However, cases will be missed by MRI due




Lymph node assessment is less accurate than T staging
with accuracies ranging between 6483%. Studies have
shown that the internal texture of an imaged node may
correlate better with the presence of metastasis than
nodal size, and that inhomogeneity and hilar reflectivity
are important discriminators of nodal status. However,
these features are not consistently reliable and the inabil-
ity to identify nodes55mm in diameter is recognised as
Figure 1 Superficial rectal tumour confined to mucosa
(T1). Note the intact hyperechoic submucosa (arrowheads)
medial to the muscularis propria (arrows). This was a mod-
erately dysplastic tubulovillous adenoma on histopathology.
Figure 2 MRI and corresponding histopathology H&E stained section of a lymph node. The MRI shows a lymph node
with an irregular border (arrow). The corresponding histopathology section shows this irregular border corresponds to
tumour breach of the lymph node capsule.
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a significant limitation of staging by EUS, with only 13%
of positive lymph nodes measuring55mm in diameter
being detected in one series.
MRI
It has been shown that mixed MR signal intensity within
lymph nodes usually corresponds histologically to
tumour deposits with areas of necrosis or extracellular
mucin pools. Evaluation of the border contour of
lymph nodes is also a good predictor of nodal status
and more accurate than using size criteria. However,
micrometastatic disease defined as tumour foci52mm
within lymph nodes cannot be identified. MRI and EUS
can be regarded as equivalent in assessment of T-stage,
however MRI has clear advantages over EUS in nodal
assessment since nodes within the entire mesorectum can
be evaluated by MRI. In addition, MRI enables assess-
ment of other crucial prognostic factors, namely extramu-
ral venous invasion and circumferential resection margin
status[3].
Extramural venous invasion
Extramural venous invasion is recognised on MRI by
characteristic serpiginous extension of tumour signal
into perirectal or pericolonic fat. Extramural venous inva-
sion is a poor predictor of survival and is also the third
strongest independent predictor of metastasis, after
lymph node status and extent of local tumour infiltration.
By careful correlation with histopathology specimens,
high-resolution MRI can identify extramural vascular
invasion (EMVI) and predicts post-operative histological
EMVI with 80% accuracy. This feature is present in up to
30% of rectal cancers and can be used to stratify patients
into clearly separate prognostic groups. Patients diag-
nosed with MRI-EMVI positive tumours have a signifi-
cantly worse outcome and a greater than 50% risk of
developing metastatic disease, compared with only 12%
for patients who are MRI-EMVI negative.
The circumferential resection margin
The mesorectal fascia represents the potential circumfer-
ential resection margin (CRM) in patients undergoing
radical total mesorectal excision (TME) surgery and its
clear demonstration on MRI enables prediction of final
CRM status following surgery[4]. We define potential
CRM involvement if tumour extends to within 1mm of
the mesorectal fascia on MR images (Fig. 2). It is well
established that a positive CRM is associated with both
local recurrence and poor survival. The pre-operative
identification of this by MRI enables patients to benefit
from therapy that causes tumour regression away from
the potential CRM prior to surgery[5].
Conclusion
Careful staging of rectal tumours results in selective pre-
operative treatment strategies aimed at reducing local
failure and distant failure in high risk patients.
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